Protalix Biotherapeutics Inc. buy marge
Start price
12.04.17
/
50%
€10.35
Target price
26.07.17
€20.00
Performance (%)
-40.29%
End price
26.07.17
€6.18
Summary
This prediction ended on 26.07.17 with a price of €6.18. Massive losses of -40.29% were the result for the BUY prediction by marge. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Protalix Biotherapeutics Inc. | 18.792% | 18.792% | -19.801% | 22.195% |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% | 65.664% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% | 111.170% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% | 55.883% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% | 67.956% |
Comments by marge for this prediction
In the thread Protalix Biotherapeutics Inc. diskutieren
marge stimmt der Buy-Einschätzung von datca zu
marge stimmt am 124.2017 der Buy-Einschätzung von datca mit dem Kursziel 2€ zu.Überschrift: Protalix for the Treatment of Cystic Fibrosis and Fabry Disease
(Vom Mitglied beendet)